Vicente Herrero‐Aguayo

Author

Instituto Maimónides de Investigación Biomédica de Córdoba ORCID

Also Known As

Herrero-Aguayo Vicente, Herrero-Aguayo, Vicente, V. Herrero-Aguayo, Vicente Herrero-Aguayo, Vicente Herrero‐Aguayo

Publications

478

Citations

H-Index

Concepts

All Affiliations

Instituto Maimónides de Investigación Biomédica de Córdoba Hospital Universitario Reina Sofía University of Córdoba Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition Centro de Investigación Biomédica en Red

About

Vicente Herrero‐Aguayo is an author at Instituto Maimónides de Investigación Biomédica de Córdoba specializing in medicine, cell biology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	241
2	Cell Biology	3	3	113
3	Engineering	1	1	75
4	Health Sciences	1	1	22
5	Biochemistry	1	1	19

Vicente Herrero‐Aguayo

Publications

436

Citations

H-Index

Page 1

	Year	Citations
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Antonio J. Montero‐Hidalgo, EBioMedicine UrologyGenitourinary CancerMedicineRna SplicingPathology	2020	109
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez, Translational research Prognostic BiomarkersSystems BiologyEngineeringMedicineBiomarker Target	2019	75
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá, Journal of Experimental & Clinical Cancer Research	2021	56
Influence of Obesity in the miRNome: miR-4454, a Key Regulator of Insulin Response Via Splicing Modulation in Prostate Vicente Herrero‐Aguayo, Juan M. Jiménez‐Vacas, Prudencio Sáez-Martínez, The Journal of Clinical Endocrinology & Metabolism	2020	31
Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Antonio J. Montero‐Hidalgo, The Journal of Clinical Endocrinology & Metabolism	2020	30
Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and <scp>IGF</scp>1 Fernando L‐López, André Sarmento‐Cabral, Vicente Herrero‐Aguayo, Journal of Cellular and Molecular Medicine Metabolic DisorderPathologyInsulin SignalingObesityMetabolic Syndrome	2017	22
Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer Enrique Gómez‐Gómez, Juan M. Jiménez‐Vacas, Julia Carrasco‐Valiente, Journal of Cellular and Molecular Medicine	2018	19
Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells Antonio J. León‐González, Prudencio Sáez-Martínez, Juan M. Jiménez‐Vacas, Antioxidants Chemoprevention StrategyBiochemistryMedicineSemisynthetic Lipophilic DerivativesProstate Cancer Cells	2021	19
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer Enrique Gómez‐Gómez, Juan M. Jiménez‐Vacas, Sergio Pedraza‐Arévalo, Journal of Clinical Medicine Oncogenic RoleUrologyGenitourinary CancerOncogenic AgentEn2 Treatment	2019	16
Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer Juan M. Jiménez‐Vacas, Enrique Gómez‐Gómez, Antonio J. Montero‐Hidalgo, Journal of Clinical Medicine	2019	14

Page 1